Ignite Creation Date:
2025-12-24 @ 9:33 PM
Ignite Modification Date:
2026-04-14 @ 10:06 PM
Study NCT ID:
NCT00310232
Status:
TERMINATED
Last Update Posted:
2024-04-02
First Post:
2006-03-31
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Epoetin Alfa in Advanced Non-Small Cell Lung Cancer (EPO-CAN-20)
Sponsor:
Ontario Clinical Oncology Group (OCOG)
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
CTA-Control-076080
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |